LD
AGN.PRA

Lipe & Dalton’s Allergan plc AGN.PRA Stock Holding History

Lipe & Dalton’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,882
Closed -$1.63M – 90
2017
Q2 		$1.63M Buy
1,882
+120
+7% +$101K 1.05% 35
2017
Q1 		$1.49M Buy
1,762
+645
+58% +$534K 1.08% 34
2016
Q4 		$850K Buy
1,117
+265
+31% +$200K 0.6% 39
2016
Q3 		$700K Buy
852
+512
+151% +$443K 0.47% 46
2016
Q2 		$283K Buy
+340
New +$284K 0.2% 65

Other funds holding AGN.PRA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $86.6B AUM 38.74% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SC
Sculptor Capital New York $8.88B AUM 27.49% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $25.9B AUM 21.78% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.56B AUM 0.92% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return